Schonfeld Strategic Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,971
| Closed | -$597K | – | 2241 |
|
|
2025
Q4 | $597K | Sell |
1,971
-299
| -13% | -$93.3K | ﹤0.01% | 1331 |
|
|
2025
Q3 | $636K | Sell |
2,270
-3,700
| -62% | -$1.01M | ﹤0.01% | 1581 |
|
|
2025
Q2 | $1.44M | Buy |
5,970
+1,540
| +35% | +$364K | 0.01% | 1150 |
|
|
2025
Q1 | $1.08M | Buy |
+4,430
| New | +$1.33M | 0.01% | 1257 |
|
|
2024
Q4 | – | Sell |
-1,400
| Closed | -$468K | – | 2020 |
|
|
2024
Q3 | $468K | Buy |
1,400
+46
| +3% | +$14.6K | ﹤0.01% | 1468 |
|
|
2024
Q2 | $370K | Buy |
+1,354
| New | +$394K | ﹤0.01% | 1600 |
|
|
2024
Q1 | – | Sell |
-1,500
| Closed | -$484K | – | 2075 |
|
|
2023
Q4 | $484K | Buy |
1,500
+478
| +47% | +$150K | ﹤0.01% | 1297 |
|
|
2023
Q3 | $366K | Sell |
1,022
-49,986
| -98% | -$19.3M | ﹤0.01% | 1288 |
|
|
2023
Q2 | $19.3M | Sell |
51,008
-166,802
| -77% | -$67.9M | 0.17% | 181 |
|
|
2023
Q1 | $104M | Buy |
217,810
+36,371
| +20% | +$17M | 1% | 2 |
|
|
2022
Q4 | $76.3M | Buy |
181,439
+6,417
| +4% | +$2.59M | 0.64% | 14 |
|
|
2022
Q3 | $73M | Sell |
175,022
-132,806
| -43% | -$66.2M | 0.61% | 7 |
|
|
2022
Q2 | $152M | Buy |
307,828
+142,870
| +87% | +$74.4M | 1.6% | 1 |
|
|
2022
Q1 | $92.9M | Sell |
164,958
-5,436
| -3% | -$3.28M | 1.04% | 6 |
|
|
2021
Q4 | $129M | Sell |
170,394
-14,772
| -8% | -$11.1M | 1.25% | 2 |
|
|
2021
Q3 | $138M | Buy |
185,166
+68,849
| +59% | +$51.6M | 1.57% | 1 |
|
|
2021
Q2 | $74.9M | Sell |
116,317
-6,940
| -6% | -$4.22M | 0.84% | 6 |
|
|
2021
Q1 | $70.4M | Buy |
123,257
+27,809
| +29% | +$16.5M | 0.93% | 7 |
|
|
2020
Q4 | $55.6M | Buy |
95,448
+59,550
| +166% | +$33.9M | 0.78% | 12 |
|
|
2020
Q3 | $18.5M | Sell |
35,898
-1,569
| -4% | -$795K | 0.37% | 48 |
|
|
2020
Q2 | $16.9M | Buy |
37,467
+7,841
| +26% | +$3.46M | 0.47% | 37 |
|
|
2020
Q1 | $10.4M | Sell |
29,626
-73,235
| -71% | -$26.9M | 0.65% | 18 |
|
|
2019
Q4 | $38.1M | Buy |
102,861
+21,202
| +26% | +$7.47M | 0.93% | 15 |
|
|
2019
Q3 | $27.2M | Buy |
81,659
+22,072
| +37% | +$7.2M | 0.8% | 15 |
|
|
2019
Q2 | $18.6M | Buy |
59,587
+42,387
| +246% | +$12.7M | 0.66% | 22 |
|
|
2019
Q1 | $5.26M | Buy |
17,200
+8,402
| +95% | +$2.27M | 0.18% | 147 |
|
|
2018
Q4 | $2.04M | Buy |
8,798
+2,798
| +47% | +$751K | 0.08% | 323 |
|
|
2018
Q3 | $1.88M | Sell |
6,000
-31,512
| -84% | -$9.78M | 0.08% | 296 |
|
|
2018
Q2 | $10.8M | Buy |
37,512
+35,989
| +2,363% | +$9.94M | 0.59% | 18 |
|
|
2018
Q1 | $381K | Sell |
1,523
-3,341
| -69% | -$851K | 0.03% | 529 |
|
|
2017
Q4 | $1.16M | Buy |
+4,864
| New | +$1.18M | 0.1% | 277 |
|
|
2017
Q2 | – | Sell |
-1,472
| Closed | -$294K | – | 615 |
|
|
2017
Q1 | $294K | Sell |
1,472
-1,730
| -54% | -$333K | 0.03% | 475 |
|
|
2016
Q4 | $584K | Buy |
+3,202
| New | +$546K | 0.08% | 311 |
|
|
2016
Q2 | – | Sell |
-2,259
| Closed | -$309K | – | 436 |
|
|
2016
Q1 | $309K | Buy |
+2,259
| New | +$297K | 0.13% | 216 |
|
Other funds holding BIO
VCM
VPM
AI
